Yoshinaga Keiichiro, Katoh Chietsugu, Noriyasu Kazuyuki, Yamada Satoshi, Ito Yoshinori, Kuge Yuji, Kawai Yuko, Kohya Tetsuro, Kitabatake Akira, Tamaki Nagara
Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Kita-Ku, Kita 15 Nishi 7, Sapporo, 060-8638, Japan.
Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):882-90. doi: 10.1007/s00259-002-0795-4. Epub 2002 Apr 13.
The detection of viable myocardium is important for the prediction of functional recovery after revascularisation. However, a fixed perfusion defect often includes viable myocardium, and perfusion imaging then underestimates myocardial viability. We previously reported that low-dose dobutamine stress gated single-photon emission tomography (SPET) provides similar findings to dobutamine stress echocardiography in the assessment of myocardial viability. The present study investigated whether low-dose dobutamine stress gated SPET is of additional value as compared with stress-rest technetium-99m tetrofosmin SPET for the detection of myocardial viability. Standard stress-rest perfusion SPET, low-dose dobutamine stress gated SPET and fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) were studied in 23 patients (mean age 67+/-7.6 years) with previous myocardial infarction. Twenty-one of them were successfully studied with each technique. FDG PET viability (FDG uptake >/=50%) was employed as the gold standard. One-day stress-rest (99m)Tc-tetrofosmin myocardial SPET was performed. After the resting study, gated SPET was acquired following infusion of 7.5 microg kg(-1) min(-1) of dobutamine. Left ventricular wall motion in 16 segments was assessed by cine mode display using a four-point scale. Myocardial viability was considered present when there was improvement by one point. Of a total of 336 segments analysed, 53 had persistent defects on stress-rest perfusion SPET. FDG viability was seen in 16 of 17 dobutamine-responsive segments, but in only 11 of 36 dobutamine non-responsive segments ( P<0.01). Thus, in the segments with persistent defects, viability findings on low-dose dobutamine stress gated SPET were concordant with those on FDG PET in 77% of segments (kappa value =0.55). For the detection of FDG-viable myocardium, the combination of stress-rest perfusion SPET and low-dose dobutamine stress gated SPET achieved a better sensitivity than stress-rest perfusion SPET alone (35/46, 76% vs 19/46, 41.3%, P<0.001), with a similar specificity (25/29, 86% vs 26/29, 90%, P=NS). We conclude that in the identification of viable myocardium, low-dose dobutamine stress gated SPET may provide additional information missed on a routine stress-rest perfusion scan. Dobutamine stress gated SPET may provide new insights into myocardial viability on the basis of ischaemia and contractile reserve.
存活心肌的检测对于预测血运重建术后的功能恢复很重要。然而,固定的灌注缺损常包含存活心肌,此时灌注成像会低估心肌存活情况。我们之前报道过,低剂量多巴酚丁胺负荷门控单光子发射断层扫描(SPET)在评估心肌存活方面与多巴酚丁胺负荷超声心动图有相似的结果。本研究调查了与静息-负荷锝-99m替曲膦SPET相比,低剂量多巴酚丁胺负荷门控SPET在检测心肌存活方面是否具有额外价值。对23例(平均年龄67±7.6岁)既往有心肌梗死的患者进行了标准静息-负荷灌注SPET、低剂量多巴酚丁胺负荷门控SPET和氟-18氟脱氧葡萄糖正电子发射断层扫描(FDG PET)研究。其中21例患者每种技术均成功完成检查。以FDG PET存活(FDG摄取≥50%)作为金标准。进行了一日静息-负荷(99m)Tc-替曲膦心肌SPET检查。静息检查后,在输注7.5μg·kg-1·min-1多巴酚丁胺后采集门控SPET。使用四点量表通过电影模式显示评估16个节段的左心室壁运动。当运动改善一个等级时,认为存在心肌存活。在总共分析的336个节段中,53个在静息-负荷灌注SPET上有持续性缺损。在17个多巴酚丁胺反应性节段中的16个节段可见FDG存活,但在36个多巴酚丁胺无反应性节段中仅11个节段可见(P<0.01)。因此,在有持续性缺损的节段中,低剂量多巴酚丁胺负荷门控SPET上的存活结果与FDG PET上的结果在77%的节段中一致(kappa值=0.55)。对于检测FDG存活心肌,静息-负荷灌注SPET与低剂量多巴酚丁胺负荷门控SPET联合使用比单独使用静息-负荷灌注SPET具有更高的敏感性(35/46,76%对19/46,41.3%,P<0.001),特异性相似(25/29,86%对26/29,90%,P=无显著性差异)。我们得出结论,在识别存活心肌方面,低剂量多巴酚丁胺负荷门控SPET可能提供常规静息-负荷灌注扫描遗漏的额外信息。多巴酚丁胺负荷门控SPET可能基于缺血和收缩储备为心肌存活提供新的见解。